InsiderTrades

Form 4 for INGN Inogen Inc

Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-15 · accession 0001209191-21-047290 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-19 2021-07-15 INGN Huggenberger Raymond Dir M - OptEx $38.54 +4,000 24.6K +19% +$154.2K
DM 2021-07-19 2021-07-15 INGN Huggenberger Raymond Dir S - Sale+OE $65.83 -7,000 17.8K -28% -$460.8K
D 2021-07-19 2021-07-15 INGN Huggenberger Raymond Dir M - OptEx $0.00 -4,000 19.8K -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-15 M A 4,000 $38.54 24,583 D — —
2 Common Common Stock 2021-07-15 S D 178 $66.62 17,583 D — — (F3) Represents the share price of an aggregate total of 178 shares sold at a price of $66.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2021-07-15 S D 6,822 $65.81 17,761 D — — (F2) Represents the weighted average share price of an aggregate total of 6,822 shares sold in the price range of $65.258 to $66.23 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (Right to Buy) 2021-07-15 M D 4,000 $0.00 19,806 D $38.54 · — to 2022-05-15 4,000 Common Stock (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.